Alimera Sciences Inc (ALIM)
3.60
+0.03
(+0.84%)
USD |
NASDAQ |
Apr 24, 16:00
3.60
0.00 (0.00%)
After-Hours: 20:00
Alimera Sciences Enterprise Value: 239.34M for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 239.34M |
| April 22, 2024 | 237.77M |
| April 19, 2024 | 227.30M |
| April 18, 2024 | 232.53M |
| April 17, 2024 | 238.29M |
| April 16, 2024 | 239.86M |
| April 15, 2024 | 237.77M |
| April 12, 2024 | 236.72M |
| April 11, 2024 | 254.00M |
| April 10, 2024 | 248.76M |
| April 09, 2024 | 251.38M |
| April 08, 2024 | 250.33M |
| April 05, 2024 | 254.00M |
| April 04, 2024 | 256.61M |
| April 03, 2024 | 259.23M |
| April 02, 2024 | 259.23M |
| April 01, 2024 | 254.00M |
| March 28, 2024 | 256.61M |
| March 27, 2024 | 256.61M |
| March 26, 2024 | 255.04M |
| March 25, 2024 | 261.33M |
| March 22, 2024 | 260.80M |
| March 21, 2024 | 262.90M |
| March 20, 2024 | 256.09M |
| March 19, 2024 | 264.47M |
| Date | Value |
|---|---|
| March 18, 2024 | 261.85M |
| March 15, 2024 | 272.84M |
| March 14, 2024 | 260.80M |
| March 13, 2024 | 252.43M |
| March 12, 2024 | 252.95M |
| March 11, 2024 | 249.81M |
| March 08, 2024 | 260.28M |
| March 07, 2024 | 256.61M |
| March 06, 2024 | 255.04M |
| March 05, 2024 | 250.33M |
| March 04, 2024 | 247.19M |
| March 01, 2024 | 246.67M |
| February 29, 2024 | 237.77M |
| February 28, 2024 | 227.30M |
| February 27, 2024 | 235.67M |
| February 26, 2024 | 229.39M |
| February 23, 2024 | 228.87M |
| February 22, 2024 | 225.72M |
| February 21, 2024 | 222.58M |
| February 20, 2024 | 230.44M |
| February 16, 2024 | 231.48M |
| February 15, 2024 | 230.44M |
| February 14, 2024 | 227.30M |
| February 13, 2024 | 250.33M |
| February 12, 2024 | 252.95M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
50.79M
Minimum
May 12 2023
308.09M
Maximum
Aug 16 2023
113.58M
Average
91.58M
Median
Enterprise Value Benchmarks
| Eli Lilly and Co | 731.37B |
| NovaBay Pharmaceuticals Inc | 2.275M |
| Palatin Technologies Inc | 18.75M |
| iBio Inc | 16.49M |
| Theriva Biologics Inc | -13.75M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.781M |
| Revenue (Quarterly) | 26.31M |
| Total Expenses (Quarterly) | 25.58M |
| EPS Diluted (Quarterly) | -0.0722 |
| Gross Profit Margin (Quarterly) | 86.22% |
| Profit Margin (Quarterly) | -14.37% |
| Earnings Yield | -60.06% |
| Normalized Earnings Yield | -40.18 |